Defensins: Potential Effectors in Autoimmune Rheumatic Disorders

Defensins are small cationic peptides with antimicrobial properties. They constitute a highly conserved innate immune defense mechanism across species. Based on the arrangement of disulfide-bonds, α- and β-defensins are distinguished in humans. Both types of defensin comprise several distinct molecu...

Full description

Bibliographic Details
Main Authors: Stefan Vordenbäumen, Matthias Schneider
Format: Article
Language:English
Published: MDPI AG 2011-08-01
Series:Polymers
Subjects:
Online Access:http://www.mdpi.com/2073-4360/3/3/1268/
_version_ 1811303242655596544
author Stefan Vordenbäumen
Matthias Schneider
author_facet Stefan Vordenbäumen
Matthias Schneider
author_sort Stefan Vordenbäumen
collection DOAJ
description Defensins are small cationic peptides with antimicrobial properties. They constitute a highly conserved innate immune defense mechanism across species. Based on the arrangement of disulfide-bonds, α- and β-defensins are distinguished in humans. Both types of defensin comprise several distinct molecules that are preferentially expressed at epithelial surfaces and in blood cells. In the last decade, multiple immunomodulatory functions of defensins have been recognized, including chemotactic activity, the promotion of antigen presentation, and modulations of proinflammatory cytokine secretion. These findings suggested a role for defensins not only as a first line of defense, but also as connectors of innate and adaptive immune responses. Recently, increasingly accumulating evidence has indicated that defensins may also be involved in the pathogenesis of autoimmune rheumatic disorders such as systemic lupus erythematosus and rheumatoid arthritis. The current review summarizes the data connecting defensins to autoimmunity.
first_indexed 2024-04-13T07:44:31Z
format Article
id doaj.art-25c7eda49bd04854b2123cdd7bd29f57
institution Directory Open Access Journal
issn 2073-4360
language English
last_indexed 2024-04-13T07:44:31Z
publishDate 2011-08-01
publisher MDPI AG
record_format Article
series Polymers
spelling doaj.art-25c7eda49bd04854b2123cdd7bd29f572022-12-22T02:55:44ZengMDPI AGPolymers2073-43602011-08-01331268128110.3390/polym3031268Defensins: Potential Effectors in Autoimmune Rheumatic DisordersStefan VordenbäumenMatthias SchneiderDefensins are small cationic peptides with antimicrobial properties. They constitute a highly conserved innate immune defense mechanism across species. Based on the arrangement of disulfide-bonds, α- and β-defensins are distinguished in humans. Both types of defensin comprise several distinct molecules that are preferentially expressed at epithelial surfaces and in blood cells. In the last decade, multiple immunomodulatory functions of defensins have been recognized, including chemotactic activity, the promotion of antigen presentation, and modulations of proinflammatory cytokine secretion. These findings suggested a role for defensins not only as a first line of defense, but also as connectors of innate and adaptive immune responses. Recently, increasingly accumulating evidence has indicated that defensins may also be involved in the pathogenesis of autoimmune rheumatic disorders such as systemic lupus erythematosus and rheumatoid arthritis. The current review summarizes the data connecting defensins to autoimmunity.http://www.mdpi.com/2073-4360/3/3/1268/defensinantimicrobial peptiderheumatologyautoimmune disease
spellingShingle Stefan Vordenbäumen
Matthias Schneider
Defensins: Potential Effectors in Autoimmune Rheumatic Disorders
Polymers
defensin
antimicrobial peptide
rheumatology
autoimmune disease
title Defensins: Potential Effectors in Autoimmune Rheumatic Disorders
title_full Defensins: Potential Effectors in Autoimmune Rheumatic Disorders
title_fullStr Defensins: Potential Effectors in Autoimmune Rheumatic Disorders
title_full_unstemmed Defensins: Potential Effectors in Autoimmune Rheumatic Disorders
title_short Defensins: Potential Effectors in Autoimmune Rheumatic Disorders
title_sort defensins potential effectors in autoimmune rheumatic disorders
topic defensin
antimicrobial peptide
rheumatology
autoimmune disease
url http://www.mdpi.com/2073-4360/3/3/1268/
work_keys_str_mv AT stefanvordenbaumen defensinspotentialeffectorsinautoimmunerheumaticdisorders
AT matthiasschneider defensinspotentialeffectorsinautoimmunerheumaticdisorders